◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

GMO U.S. Quality ETF (QLTY) ETF Overview

Name: GMO U.S. Quality ETF (QLTY) price history and fund statistics
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Price history, fund statistics and profile — an exchange-traded fund.

Exchange-Traded Funds · Large Blend · DATA UPDATED 2026-08-16

GMO U.S. Quality ETF (QLTY) is an exchange-traded fund managed by GMO in the "Large Blend" category. It manages roughly $5 billion in assets.

The fund is an actively managed exchange-traded fund that seeks to achieve its investment objective by investing primarily in equities of U.S. companies that the fund’s adviser, Grantham, Mayo, Van Otterloo & Co. LLC (“GMO” or the “Adviser”), believes to be of high quality.

Interactive chart & fund stats →

QLTY Fund Statistics

Expense ratio	0.50%
Trailing yield	0.72%
Assets under management	$5 billion
Fund category	Large Blend
Fund family	GMO
Inception	2023-11-13

The live price chart, fund profile and news are in the interactive QLTY viewer.

Other Companies in Large Blend

RECS · Columbia Research Enhanced Core ETF — $6 billion
SCHK · Schwab 1000 ETF — $6 billion
BKLC · BNY Mellon US Large Cap Core Equity ETF — $5 billion
DSI · iShares ESG MSCI KLD 400 ETF — $5 billion
OMFL · Invesco Russell 1000 Dynamic Multifactor ETF — $5 billion
EAGL · Silver Eagle Acquisition Corp. Common Stock — $4 billion
TSPA · T. Rowe Price US Equity Research ETF — $4 billion
SUSA · iShares ESG Optimized MSCI USA ETF — $4 billion

← QLT All “Q” companies QLYS →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.